Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type

被引:1
作者
Hong, Junshik [1 ]
Park, Sanghui [2 ]
Baek, Hae Lim [1 ]
Jung, Joo Hyun [3 ]
Kang, Il Gyu [3 ]
Sym, Sun Jin [1 ]
Park, Jinny [1 ]
Ahn, Jeong Yeal
Cho, Eun Kyung [1 ]
Kim, Seon Tae [3 ]
Shin, Dong Bok [1 ]
Lee, Jae Hoon [1 ]
机构
[1] Gachon Univ, Dept Internal Med, Sch Med, Inchon 405760, South Korea
[2] Ewha Womans Univ, Dept Pathol, Sch Med, Seoul 158710, South Korea
[3] Gachon Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Inchon 405760, South Korea
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2012年 / 5卷 / 09期
关键词
Extranodal NK/T-cell lymphoma; nasal type; epstein-barr virus; CD30; prognosis; nuclear diameter; T-CELL; ASSOCIATION; MUTATIONS; DISEASE; TAIWAN; HEALTH; JAPAN; P53;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Extranodal natural killer/T-cell lymphoma, nasal type (nasal ENKTL) is a distinct clinicopathologic entity of lymphoid tumors with variable size and differentiation of tumor cells. Nasal ENKTL is related to infection of the tumor cells with Epstein-Barr virus (EBV) and virtually all cases contain monoclonal episomal EBV DNA and detectable EBV encoded small nuclear RNAs (EBERs). Several clinical factors are known for their relation to the prognosis, but histopathologic prognostic factors of nasal ENKTL have not yet been well established. We evaluated the prognostic value of the longest nuclear diameter of EBER+ tumor cells (NDTC) along with the result of CD30 expression. Twenty two patients with newly diagnosed nasal ENKTL were evaluated regarding clinicopathologic characteristics. NDTC was measured using a computerized image analysis system. The results were expressed as the mean diameter of >= 50 cells in a patient. Median of the mean NDTC of the patients was 7.32 mu m (5.15-11.27). Patients with larger mean NDTC (>= 7.35 mu m) had a poorer event-free survival (EFS) than those with smaller mean NDTC (< 7.35 mu m; p = 0.024) and had a tendency of inferior overall survival (OS) (p = 0.08). Patients with CD30 expression had a inferior EFS (p = 0.018) and OS (p = 0.011) compared those without CD30 expression. The NDTC of EBV infected tumor cell and CD30 expression had relation to survival in the current exploratory analysis.
引用
收藏
页码:939 / 947
页数:9
相关论文
共 31 条
  • [1] NATION-WIDE STUDY OF LETHAL MID-LINE GRANULOMA IN JAPAN - FREQUENCIES OF WEGENER GRANULOMATOSIS, POLYMORPHIC RETICULOSIS, MALIGNANT-LYMPHOMA AND OTHER RELATED CONDITIONS
    AOZASA, K
    OHSAWA, M
    TAJIMA, K
    SASAKI, R
    MAEDA, H
    MATSUNAGA, T
    FRIEDMANN, I
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (01) : 63 - 66
  • [2] Angiocentric nasal T/natural killer cell lymphoma:: a single centre study of prognostic factors in 108 patients
    Avilés, A
    Díaz, NR
    Neri, N
    Cleto, S
    Talavera, A
    [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 2000, 22 (04): : 215 - 220
  • [3] Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma
    Beltran, Brady
    Quinones, Pilar
    Morales, Domingo
    Cotrina, Esther
    Castillo, Jorge J.
    [J]. LEUKEMIA RESEARCH, 2011, 35 (03) : 334 - 339
  • [4] Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T cell lymphoma:: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
    Bossard, Celine
    Belhadj, Karim
    Reyes, Felix
    Martin-Garcia, Nadine
    Berger, Francoise
    Kummer, Jean Alain
    Briere, Josette
    Baglin, Anne-Catherine
    Cheze, Stephane
    Bosq, Jacques
    Ribrag, Vincent
    Gisselbrecht, Christian
    Mounier, Nicolas
    Gaulard, Philippe
    [J]. BLOOD, 2007, 109 (05) : 2183 - 2189
  • [5] Early stage nasal NK/T-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality
    Cheung, MMC
    Chan, JKC
    Lau, WH
    Ngan, RKC
    Foo, WWL
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01): : 182 - 190
  • [6] CD30 in normal and neoplastic cells
    Chiarle, R
    Podda, A
    Prolla, G
    Gong, J
    Thorbecke, GJ
    Inghirami, G
    [J]. CLINICAL IMMUNOLOGY, 1999, 90 (02) : 157 - 164
  • [7] Sinonasal NK/T-cell lymphomas in the United States
    Gaal, K
    Sun, NCJ
    Hernandez, AM
    Arber, DA
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (11) : 1511 - 1517
  • [8] Natural killer cell neoplasm: biology and pathology
    Ham, Maria Francisca
    Ko, Young-Hyeh
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (05) : 681 - 689
  • [9] World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997
    Harris, NL
    Jaffe, ES
    Diebold, J
    Flandrin, G
    Muller-Hermelink, HK
    Vardiman, J
    Lister, TA
    Bloomfield, CD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3835 - 3849
  • [10] CD30: expression and function in health and disease
    Horie, R
    Watanabe, T
    [J]. SEMINARS IN IMMUNOLOGY, 1998, 10 (06) : 457 - 470